Deceased organ donors where the cause of death is meningitis or encephalitis are a potential concern because of the risks of transmission of a potentially fatal infection to recipients. Using the UK Transplant Registry, a retrospective cohort analysis of deceased organ donors in the UK was undertaken to better understand the extent to which organs from deceased donors with meningitis and encephalitis (of both known and unknown cause) have been used for transplantation, and to determine the 
Introduction
The demand for organs for transplantation far exceeds supply and increasing consideration is being given to the use of organs from sub-optimal donors, including those perceived to pose a potential increased risk of disease transmission to the recipient (1, 2) . Donors who have a died as a result of meningitis or encephalitis are of potential concern because of the risk of transmitting life threatening meningitis or encephalitis to the immunocompromised recipient (2, 3) . This risk was highlighted by a recent case in the United Kingdom (UK) where an encephalitis of unknown cause was transmitted from the donor and killed both renal transplant recipients (4) . Cases of meningitis and encephalitis transmission have been observed in the United States (US) and Europe, with the transmission often proving fatal (5) (6) (7) (8) (9) (10) (11) (12) (13) . The risk of disease transmission needs to be evaluated and balanced against the potential benefit of providing additional donor organs for transplantation to the recipient population.
UK guidelines from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) (2011) state that 'Material from cases of meningo-encephalitis for which no infection is identified should not be used for donation'.The guidelines also state that 'if there is any possibility of acquisition of a neurotropic infection from abroad the donation is contraindicated owing to the risk of rabies, West Nile virus or other exotic neurotropic infections'. However, there is a caveat in the guidance that recognises there may be a clinical need for transplantation of such urgency that it is appropriate to consider the use of organs and tissues for life-preserving purposes from donors who would not otherwise be considered eligible to donate, due to a known or perceived risk of disease transmission (14) . SaBTO guidance also states that 'if bacterial meningitis has been confirmed, but there is no visible damage or local infection in the organ or tissues required at retrieval, the donation of the organs, tissues and cells are acceptable' for transplantation (14) .
US guidance (2013) also states that donors dying of encephalitis without a proven cause should likely be avoided' (15) . The UK and US guidance is mirrored by that from the Council of Europe (2015) , which states that 'if the aetiology of an active infection cannot be established the donor is not a suitable candidate for donation' (16) .
Despite current guidance, organs from donors where the cause of meningitis and encephalitis is not known continue to be used for transplantation, as clinicians balance the risk of donor transmitted disease against the risk of death on the waiting list whilst awaiting a graft. In this study we reviewed the UK experience, to better understand the extent to which organs from deceased donors with meningitis or encephalitis (of both known and unknown cause) have been used for transplantation, and to determine the associated recipient outcomes.
Methods

Identification of deceased donors who died of Meningitis and Encephalitis
The UK Transplant Registry (UKTR) held by NHSBT was examined to identify deceased donors between 1 st January 2003 and 31 st December 2014, where the cause of death was meningitis and/or encephalitis, and who donated one or more organs for transplantation. All UK deceased donors whose cause of death was coded in the UKTR as 'meningitis' were readily identified. However, the designated codes for cause of death in the UKTR are limited to any one of 65 possible causes and there is no code for encephalitis on the registry currently, leaving the data entry team the option of coding cases of encephalitis as 'meningitis', 'infection-type unclassified', 'other', 'other-please specify' and 'unknown' and using the free text entry to specify encephalitis as the cause of death. All free text entries in the registry for donors whose primary cause of death was coded as 'meningitis,' were fully reviewed to identify if the infection had been recorded as viral, bacterial, was not known or was unstated, and whether the causal infectious agent had been recorded. For deaths coded as 'infection-type unclassified', 'other', 'other-please specify' and 'unknown', free text entries were searched using the search terms 'Meningitis', 'Encephalitis', 'Meningoencephalitis', and common misspellings of these terms to identify any additional donors where the cause of death was meningitis/encephalitis and to find whether the causal agent had been identified. The information on organ donors entered into the UKTR is that entered at time of donation, and any subsequent changes in cause of death or in causative agent for meningitis or encephalitis are relayed to the recipient centres but not changed on the registry.
Identification of potential donors who died of Meningitis or Encephalitis
The Potential Donor Audit (PDA), held by NHSBT, is a prospectively collected registry of all patients aged less than 80 years who died in critical care units of all acute hospitals in the UK. The PDA inclusion criteria changed over the study period, 
Statistical Analysis
Principal univariate analyses reported deceased donor and recipient characteristics by donor meningitis and encephalitis status (known cause meningitis and encephalitis (KME), unknown cause meningitis an encephalitis (UKME), other) using percentages, means or median and standard deviations or interquartile ranges as appropriate. Univariate analysis was carried out using t-test for continuous data.
Comparisons between groups were made using χ 2 -tests for categorical data, and unpaired difference tests for continuous data (one-way ANOVA if normality can be assumed, Kruskal-Wallis test otherwise).
Kaplan-Meier curves were used to compare death-censored graft survival and patient survival across donor cause of death groups. The univariate log-rank test was used to calculate p-values from this.
All analyses were performed using Statistical Analysis System (SAS) (version 9.3) and P-values less then 0.05 were deemed to be statistically significant (17) . bilirubin, and serum sodium (19) .
Results
Identification of donors who died from meningitis or encephalitis
A total of 258 (2.4%) of the 11,530 deceased donors, who donated one or more organs for transplantation, were identified as having died of a meningitis or encephalitis over the 12 year study period. Of the 258 organ donors identified, 214
(1.9%) were directly coded by the UKTR as having died of meningitis (figure1). A further 44 donors were not coded as meningitis but it was clear from free text entries that they had died of meningitis or encephalitis/meningo-encephalitis. Further analysis of free text entries in the UKTR for these donors showed that 221 (85.7%) had meningitis and the remaining 37 (14.3%) had encephalitis or meningoencephalitis.
There were 221 organ donors who died from meningitis of which 169 (76.5%) had a bacterial cause, 2 (1.4%) a viral cause. In 43 (19.5%) of cases the aetiology of the meningitis was unknown and in 7 (3.2%) it was unstated (figure 1). Thirty-seven donors died from encephalitis and/or meningo-encephalitis, for which a bacterial cause was thought to be responsible in 11 (29.7%), a viral cause in 6 (16.2%) and in 20 (54.1%) of cases, the cause was unknown. Where the cause of meningitis or encephalitis was known, the causative infectious organism was stated in 63% of meningitides and 19% of encephalitides ( Table 1) . Most of the bacterial meningitides were attributed to a streptococcal or meningococcal cause.
The UK Potential Donor Audit was scrutinized to identify potential organ donors aged less than 80 years with meningitis or encephalitis that did not proceed to organ donation and therefore were not entered on the organ donor transplant registry.
Over the 12-year study period, a total of 692 non-proceeding potential organ donors died of meningitis/encephalitis and did not donate organs for transplantation. Of these potential donors, 84 (12%) had encephalitis and 608 (88%) had meningitis. 
Characteristics of donors who died of meningitis and encephalitis
The clinical characteristics of the 221 organ donors with meningitis and the 37 donors with encephalitis were very similar and were, therefore, combined and compared to those donors who died of all other causes during the study period (Table 2) . Organ donors who died of meningitis or encephalitis were younger and more often donation after brain death (DBD) then donation after circulatory death (DCD) donors. They also, on average, donated more organs and more of the donated organs were transplanted. Overall, donors with meningitis or encephalitis had a lower body mass index (BMI), a lower incidence of hypertension and of cardiac disease, and were less often smokers.
Characteristics of recipients receiving organs from donors who died of meningitis and encephalitis
The 258 organ donors with meningitis and encephalitis provided a total of 899 solid organs that were transplanted. These included 455 kidneys, 237 livers, 71 hearts, 44 lungs, 7 heart and lung, 72 pancreas glands and 13 other solid organ transplants. The types of organs transplanted were similar in deceased donors with known and unknown causes of meningitis and encephalitis (data not shown).
Kidney Transplant Recipients
UK centres transplanted a total of 455 kidneys from donors who died of known and unknown causes of meningitis and encephalitis. All 24 UK transplant centres accepted kidneys from donors with both KME and UKME ( figure 3 ). Over the entire study period, these comprised 1-11% of the total number of renal transplants performed ( figure 3 ). There was no clear relationship between the volume of transplant activity at a particular transplant centre and the proportion of transplants performed using kidneys from donors with KME and UKME. The clinical characteristics of recipients who received kidneys from donors who died with an unknown cause and those with a known cause (bacterial or viral) of meningitis or encephalitis are shown separately and are compared with the recipients of organs from donors without meningitis or encephalitis (Table 3 ). There were no major clinical differences between recipients who received kidneys from donors who died of known and unknown causes of meningitis and encephalitis. Overall recipients who received kidneys from donors with meningitis or encephalitis were markedly younger than those who received kidneys from deceased donors who died from other causes.
The recipients of kidneys from donors with UKME and KME received kidneys, which had a better HLA-match than those from donors who died from other causes.
Liver Transplant Recipients
The clinical characteristics of the 237 liver transplant recipients who received livers from organ donors with KME and UKME are shown in supplementary table 1 along with the characteristics of recipients of livers from donors who died of all other causes. The recipients of livers from KME donors and UKME donors were significantly younger than recipients of livers from donors who died of all other causes. Livers from UKME donors were more frequently allocated to recipients on the super-urgent waiting list (the most urgent category).
Heart Transplant Recipients
Over the study period 71 hearts were transplanted from donors who died of meningitis and encephalitis (supplementary table 2 ). Recipients from donors who died of meningitis/encephalitis were younger, and were much more likely to require a heart urgently in comparison to recipients of hearts from donors who died of all other causes (supplementary table 2 ).
Recipient outcomes after transplantation
Of the 899 recipients who received transplants from donors with UKME and KME there were 2 early deaths attributable to donor transmission of encephalitis. The donor was a 39-year-old male who died in hospital with a meningo-encephalitis of unknown aetiology. The renal recipients, males aged 67 and 42, died of encephalitis 17 days and 19 days respectively following transplantation. On post-mortem examination, the transmitted organism was found to be the nematode infection Halicephalobus gingivalis. It is the first documented UK case and first documented human-to-human transmission of this organism, and the 6 th , 7 th and 8 th documented cases of human infection. The UKTR did not include any other reports of death, graft loss or major morbidity secondary to disease transmission from any of the other donors with UKME or KME. Only one other of the 455 recipients of kidneys from donors with UKME or KME died within 30 days of transplantation, and death in this case was attributed to cardiovascular disease, giving a thirty day mortality of 0.7%, which is similar to the thirty-day mortality in renal transplant recipients who received kidneys from donors who died of all other causes (153 deaths in 19,095 recipients (0.8%)).In the 444 recipients of non-renal organs from donors with UKME and KME, there were 14 deaths within 30 days (3.2% 30 day mortality rate vs. 3.7% in recipients of organs from donors without UKME or KME), of which 3 deaths were attributed to a neurological cause and in all of these this was a cerebrovascular accident (CVA). Of the three deaths from CVA, one recipient died of an ischemic stroke 11 days after receiving a liver from a donor with an unknown cause of encephalitis who also donated 2 kidneys for transplantation, one recipient died of a stroke (type unstated) 28 days after receiving a liver from a donor with a unknown cause of meningitis who also donated 2 kidneys for transplantation, and one recipient died of a haemorrhagic stroke12 days after receiving a heart from a donor with E.coli meningitis who donated 2 kidneys and a liver for transplantation. In none of these three patients was any mention made in the free text entries to suggest the CVAs were in any way related to the transmission of infection.
Overall patient survival was significantly better in recipients of kidneys from donors with KME (p=0.002). After adjustment using cox proportional hazard model the survival advantage was secondary to lower donor age, lower recipient age, a greater proportion being DBD donors and the donors possessing fewer comorbidities (p=0.06) (data not shown). Death censored graft survival for recipients of kidneys from donors with KME was greater than that for recipients of kidneys from donors who died of any other cause of death, but this difference failed to reach statistical significance ( Figure 4 ). Patient and graft survival was similar for kidney recipients from UKME donors and recipients from donors who died from other causes.
Death Censored graft survival and patient survival were comparable for heart and liver recipients from UKME and KME donors when compared to all other cause of death heart and liver transplant recipients ( Figure 5 and supplementary figure 1 ).
Discussion
The present UK registry analysis was undertaken to determine the extent to which The number of actual organ donors with meningitis or encephalitis was around a third of the number of potential donors identified from the UK potential donor audit dying with meningitis or encephalitis but whose organs were not used for transplantation.
This figure is considerably higher than the overall percentage of actual to potential organ donors identified from the UK potential donor audit (20) . Unfortunately, the data available in the UK PDA was not sufficiently detailed to allow us to determine precisely why potential donors with meningitis and encephalitis did not proceed to become actual organ donors, but in at least 18.7% of cases the reason cited was the underlying cause of death, and presumably concern by recipient centres about disease transmission. However, it is impossible to estimate how many of these unused potential organ donors could have transmitted a fatal disease to recipients, and hence how many potential lives were saved through not using these organs for transplantation. 
